You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Functionalizing Non-Useable Cryopreserved Human Hepatocytes into Useable Hepatic

    SBC: SCIKON INNOVATION, INC.            Topic: NIEHS

    DESCRIPTION (provided by applicant): The first isolated human hepatoctyte 2D culture, in 1981, provided baseline protocols to support freshly isolated and immediately cultured populations. With cryopreservation technology, human hepatocytes are commercially-available on demand, however, about 75% of the world stores of cryopreserved human hepatocytes are below industry quality control standards an ...

    SBIR Phase I 2011 Department of Health and Human ServicesNational Institutes of Health
  2. Development of Small Molecules to Combat Bacterial Biofilms

    SBC: AGILE SCIENCES, INC.            Topic: NIGMS

    DESCRIPTION (provided by applicant): Bacterial infections are responsible for an estimated 100,000 deaths in the United States each year, and despite the dire unmet medical need, few new treatment options are being developed. One of the most significant hurdles in effectively treating bacterial infections is the propensity of bacteria to form biofilms. The biofilm serves to protect the bacteri ...

    SBIR Phase I 2011 Department of Health and Human ServicesNational Institutes of Health
  3. Production of recombinant human glucocerebrosidase in Escherichia coli

    SBC: Glycobia, Inc.            Topic: NIGMS

    DESCRIPTION (provided by applicant): Gaucher's disease is the most common lysosomal storage disease in humans resulting in the harmful accumulation of fatty glucocerebroside in the spleen, liver, lungs, bone marrow, and brain. Gaucher patients exhibit a hereditary deficiency of glucocerebrosidase (GCase), but effective enzyme replacement therapy is available for most patients with Gaucher ...

    SBIR Phase I 2011 Department of Health and Human ServicesNational Institutes of Health
  4. Feasibility of Supercritical Carbon Dioxide Sterilization for Absorbable Suture M

    SBC: NOVASTERILIS, INC.            Topic: NIGMS

    DESCRIPTION (provided by applicant): Over the past several decades there has been relatively little innovation in the arena of medical device sterilization. Ethylene oxide (ETO) and gamma irradiation (3-irradiation) are the only technologies currently available for medical devices. In particular, synthetic polymeric medical devices are sterilized almost exclusively by ETO due to undesirable chemic ...

    SBIR Phase I 2011 Department of Health and Human ServicesNational Institutes of Health
  5. Nanoporous Membranes for cellular microarrays and in vitro assays

    SBC: Simpore Inc.            Topic: NIGMS

    DESCRIPTION (provided by applicant): Advances in protein and DNA microarrays have enabled dramatic increases in throughput and equipment standardization has made these techniques more commonplace. High density, high throughput microarrays reduce the cost of research and development in drug discovery and basic science by decreasing reagent volumes and increasing the number of experiments per plate. ...

    SBIR Phase I 2011 Department of Health and Human ServicesNational Institutes of Health
  6. Delivery of Adipose Derived Stem Cells for Healing Surgical Hernia Repairs

    SBC: AFFINERGY, LLC            Topic: NIGMS

    DESCRIPTION (provided by applicant): Over 700,000 surgical hernia repairs are performed each year in the United States and despite recent advances, a significant rate of recurrence persists. Incisional or visceral hernia repairs account for 100,000 of these surgeries costing 1.7B annually, and have a recurrence rate of 25% for an initial repair and 44% after a second repair. The incorporation of b ...

    SBIR Phase I 2011 Department of Health and Human ServicesNational Institutes of Health
  7. Disconnected Youth and Gangs in the United States

    SBC: INDEPENDENT LIVING RESOURCES, INC.            Topic: NICHD

    DESCRIPTION (provided by applicant): The purpose of this project is to develop, produce, and evaluate a competency-based multimedia, eLearning course for human service professionals. The overall program will be used to deliver a 21/2 -hour, six-module, eLearning course on the web, providing users with a home or agency-based technology for receiving a high quality and comprehensive continuing educa ...

    SBIR Phase I 2011 Department of Health and Human ServicesNational Institutes of Health
  8. Placental shape features, gestational timing and maternal and infant health

    SBC: Placental Analytics            Topic: NICHD

    DESCRIPTION (provided by applicant): The development of the placenta is a principal determinant of pregnancy outcome including prematurity, preeclampsia and fetal growth/ birth weight. In turn, next-pregnancy (maternal) risks as well as (newborn) risks ofa wide variety of childhood and adult health outcomes have been reported to be predicted by pregnancy outcomes, with these outcomes serving as pr ...

    SBIR Phase I 2011 Department of Health and Human ServicesNational Institutes of Health
  9. An automated microfluidic platform for high-throughput newborn SCID screening

    SBC: ADVANCED LIQUID LOGIC            Topic: NICHD

    DESCRIPTION (provided by applicant): The overall goal of this research collaboration is to develop a high-throughput digital microfluidic instrument capable of screening dozens of newborns simultaneously for severe combined immunodeficiency (SCID). There is a significant need at the state-screening level for such a technology platform given that on January 21, 2010, a federal Advisory Committee on ...

    SBIR Phase I 2011 Department of Health and Human ServicesNational Institutes of Health
  10. Microfluidic DNA Quality Control Solutions for Biobanks

    SBC: ADVANCED LIQUID LOGIC            Topic: NHGRI

    DESCRIPTION (provided by applicant): Recent technological advances in genotyping and DNA sequencing platforms have enabled ever larger and more ambitious projects aimed at understanding the genetic basis of human disease. Specialized biobanks have emergedto meet the needs of these studies by providing for the centralized collection, storage and management of 100,000's of samples. Maintaining ...

    SBIR Phase I 2011 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government